{"title":"Analysis of Conventional and Enhanced-Biocompatibility ZnO/Ag Heterojunction Nanorod-Based Advanced Root Canal Sealers.","authors":"Gayathri Velusamy, Aleena Unnikrishnan, Dinesh Veeran Ponnuvelu, Selvakumar Rajendran, Sungsu Park, Biji Pullithadathil","doi":"10.3390/bioengineering12090917","DOIUrl":null,"url":null,"abstract":"<p><p>This investigation aims to evaluate the biocompatibility and assess the cytotoxicity of synthesized ZnO/Ag heterojunction nanorods with commercially available root canal sealers in India. Among the commercially available root canal sealers, zinc oxide (ZnO) eugenol-based sealers are widely utilized as per Grossmann's requirements. However, these ZnO eugenol-based sealers often experience solubility issues and tissue reactions in contact with periapical tissues. To overcome the inexplicable reactivity of ZnO eugenol-based sealers, nano ZnO and nano ZnO/Ag heterojunction materials have been developed via a wet-chemical approach and studied to assess their biocompatibility and cytotoxicity. The findings of our study revealed that nano ZnO/Ag heterojunction material possesses a higher degree of biocompatibility and low cytotoxicity as compared to conventional ZnO eugenol-based sealers, attributed to its high surface-to-volume ratio, the enhanced penetration of nanosized sealers into dentinal tubules, and the synergistic spillover sensitization effect of nano ZnO combined with Ag nanoclusters. From this comparative evaluation of root canal sealers, the usage of nano ZnO/Ag heterojunction materials was found to be significantly advantageous over commercial zinc oxide eugenol-based sealers and may find profound usage with a long shelf-life.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 9","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467648/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12090917","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
This investigation aims to evaluate the biocompatibility and assess the cytotoxicity of synthesized ZnO/Ag heterojunction nanorods with commercially available root canal sealers in India. Among the commercially available root canal sealers, zinc oxide (ZnO) eugenol-based sealers are widely utilized as per Grossmann's requirements. However, these ZnO eugenol-based sealers often experience solubility issues and tissue reactions in contact with periapical tissues. To overcome the inexplicable reactivity of ZnO eugenol-based sealers, nano ZnO and nano ZnO/Ag heterojunction materials have been developed via a wet-chemical approach and studied to assess their biocompatibility and cytotoxicity. The findings of our study revealed that nano ZnO/Ag heterojunction material possesses a higher degree of biocompatibility and low cytotoxicity as compared to conventional ZnO eugenol-based sealers, attributed to its high surface-to-volume ratio, the enhanced penetration of nanosized sealers into dentinal tubules, and the synergistic spillover sensitization effect of nano ZnO combined with Ag nanoclusters. From this comparative evaluation of root canal sealers, the usage of nano ZnO/Ag heterojunction materials was found to be significantly advantageous over commercial zinc oxide eugenol-based sealers and may find profound usage with a long shelf-life.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering